{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:25:31Z","timestamp":1793424331724,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1186\/s13613-025-01469-5","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T20:59:06Z","timestamp":1744405146000},"page":"52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of aminoglycosides on survival rate and renal outcomes in patients with urosepsis: a multicenter retrospective study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7771-0053","authenticated-orcid":false,"given":"David","family":"Rozenblat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Serret-Larmande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Arrestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Benghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"D\u00e9pret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Luc","family":"Donay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Jacquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Poupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-025-01469-5_bb0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1473-3099(12)70239-6","article-title":"Outcomes of the surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study","volume":"12","author":"Levy","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1186\/s13613-025-01469-5_bb0015","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc12598","article-title":"The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study","volume":"17","author":"Quenot","year":"2013","journal-title":"Crit Care"},{"key":"10.1186\/s13613-025-01469-5_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intens Care Med"},{"key":"10.1186\/s13613-025-01469-5_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.6004","article-title":"Assessment of health care exposures and outcomes in adult patients with sepsis and septic shock","volume":"3","author":"Fay","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1186\/s13613-025-01469-5_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13613-023-01106-z","article-title":"Efficacy of carbapenem vs. non carbapenem \u03b2-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum \u03b2-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study","volume":"13","author":"Cariou","year":"2023","journal-title":"Ann Intens Care"},{"key":"10.1186\/s13613-025-01469-5_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMcp1702758","article-title":"Acute pyelonephritis in adults","volume":"378","author":"Johnson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-025-01469-5_bb0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","article-title":"Practice guidelines for the management of adult community-acquired urinary tract infections","volume":"48","author":"Caron","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1186\/s13613-025-01469-5_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European association of urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"},{"key":"10.1186\/s13613-025-01469-5_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13613-021-00834-4","article-title":"An international survey on aminoglycoside practices in critically ill patients: the AMINO III study","volume":"11","author":"Network","year":"2021","journal-title":"Ann Intens Care"},{"key":"10.1186\/s13613-025-01469-5_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkn469","article-title":"Aminoglycoside drugs in clinical practice: an evidence-based approach","volume":"63","author":"Leibovici","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-025-01469-5_bb0060","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/antibiotics12050860","article-title":"Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens","volume":"12","author":"Thy","year":"2023","journal-title":"Antibiotics"},{"key":"10.1186\/s13613-025-01469-5_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/infdis\/131.4.367","article-title":"Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus","volume":"131","author":"Sande","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1186\/s13613-025-01469-5_bb0070","first-page":"118","article-title":"Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis","volume":"88","author":"Sande","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1186\/s13613-025-01469-5_bb0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01469-5_bb0080","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis*","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01469-5_bb0085","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/AAC.00115-10","article-title":"Influence of empiric therapy with a \u03b2-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms","volume":"54","author":"Mart\u00ednez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-025-01469-5_bb0090","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis","volume":"54","author":"Micek","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-025-01469-5_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock*","volume":"40","author":"Legrand","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-025-01469-5_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int"},{"key":"10.1186\/s13613-025-01469-5_bb0105","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.11290821","article-title":"Drug-induced acute kidney injury","author":"Perazella","year":"2022","journal-title":"Clin J Am Soc Nephrol CJN"},{"key":"10.1186\/s13613-025-01469-5_bb0110","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc6863","article-title":"Early acute kidney injury and sepsis: a multicentre evaluation","volume":"12","author":"the ANZICS Database Management Committee","year":"2008","journal-title":"Crit Care"},{"key":"10.1186\/s13613-025-01469-5_bb0115","doi-asserted-by":"crossref","first-page":"c276","DOI":"10.1159\/000313486","article-title":"Evaluation of sepsis\/systemic inflammatory response syndrome, acute kidney injury, and RIFLE criteria in two tertiary hospital intensive care units in Turkey","volume":"115","author":"Yegenaga","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1186\/s13613-025-01469-5_bb0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/aas.12133","article-title":"Acute kidney injury in patients with severe sepsis in Finnish intensive care units: severe sepsis-associated AKI","volume":"57","author":"Poukkanen","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1186\/s13613-025-01469-5_bb0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs. norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"10.1186\/s13613-025-01469-5_bb0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","article-title":"Acute kidney injury in sepsis","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intens Care Med"},{"key":"10.1186\/s13613-025-01469-5_bb0135","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1186\/s13613-025-01469-5_bb0140","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/1469-0691.12089","article-title":"Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance","volume":"19","author":"Horcajada","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1186\/s13613-025-01469-5_bb0145","first-page":"1","article-title":"Clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1186\/s13613-025-01469-5_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000363725","article-title":"Clinical trial endpoints in acute kidney injury","volume":"127","author":"Billings","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"10.1186\/s13613-025-01469-5_bb0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.ajkd.2016.05.033","article-title":"End points for clinical trials in acute kidney injury","volume":"69","author":"Leaf","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1186\/s13613-025-01469-5_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13613-020-00657-9","article-title":"SEA-MAKE score as a tool for predicting major adverse kidney events in critically ill patients with acute kidney injury: results from the SEA-AKI study","volume":"10","author":"Sukmark","year":"2020","journal-title":"Ann Intens Care"},{"key":"10.1186\/s13613-025-01469-5_bb0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.12791211","article-title":"Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology","volume":"7","author":"Palevsky","year":"2012","journal-title":"CJASN"},{"key":"10.1186\/s13613-025-01469-5_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwy201","article-title":"Addressing extreme propensity scores via the overlap weights","author":"Li","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1186\/s13613-025-01469-5_bb0175","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1186\/s13613-025-01469-5_bb0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar Behav Res"},{"key":"10.1186\/s13613-025-01469-5_bb0185","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR)","volume":"61","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1186\/s13613-025-01469-5_bb0190","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/jcm12093188","article-title":"2023 update on sepsis and septic shock in adult patients: management in the emergency department","volume":"12","author":"Guarino","year":"2023","journal-title":"JCM"},{"key":"10.1186\/s13613-025-01469-5_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003344.pub3","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2014","journal-title":"Cochrane Datab Syst Rev"},{"key":"10.1186\/s13613-025-01469-5_bb0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s13054-020-03284-9","article-title":"Aminoglycosides for the treatment of septic shock: a propensity-based study","volume":"24","author":"Llitjos","year":"2020","journal-title":"Crit Care"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01469-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-025-01469-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-025-01469-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:44:30Z","timestamp":1776671070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2110582025000597"],"URL":"https:\/\/doi.org\/10.1186\/s13613-025-01469-5","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of aminoglycosides on survival rate and renal outcomes in patients with urosepsis: a multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-025-01469-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Author(s) 2025. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"52"}}